Blog

AimedBio
Pharma

Boehringer Ingelheim Puts Up Nearly $1B to License Cancer Candidate From AimedBio

Editorial Team
  • October 17, 2025
  • 5 min read
zaltenibart
Pharma

Novo Acquires Global Rights to Omeros’ Rare Disease Drug Zaltenibart in $2.1 Billion Deal

Editorial Team
  • October 17, 2025
  • 4 min read
BCBS Global Solutions
Hospitals & Providers

BCBS Global Solutions Collaborates with Carrot for Expatriate Health Services

Editorial Team
  • October 16, 2025
  • 4 min read
lenacapavir
Health

Gilead and Global Fund Finalize HIV Prevention Drug Strategy for Low-Income Countries

Admin
  • October 15, 2025
  • 4 min read
astrazeneca
Pharma

AstraZeneca Reaches Agreement with Trump Administration on Direct-to-Consumer Drug Pricing

Editorial Team
  • October 14, 2025
  • 4 min read
Search
Recent Post
Oscar Health
Oscar Health Announces Lucie, Its Go-To Platform
  • April 20, 2026
  • 4 min read
Lilly
According to a study by Lilly, the
  • April 18, 2026
  • 4 min read
Beeline Medicines
Beeline Medicines, sponsored by Bain, emerges from
  • April 18, 2026
  • 5 min read

Categories

Stay In Touch

© 2025 Healthcare Chief. All rights reserved